Caxton Corp Xeris Biopharma Holdings, Inc. Transaction History
Caxton Corp
- $23.3 Million
- Q3 2024
A detailed history of Caxton Corp transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Caxton Corp holds 5,113,348 shares of XERS stock, worth $17.5 Million. This represents 62.59% of its overall portfolio holdings.
Number of Shares
5,113,348
Previous 5,113,348
-0.0%
Holding current value
$17.5 Million
Previous $11.5 Million
26.67%
% of portfolio
62.59%
Previous 61.49%
Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
143Shares Held
60MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$35.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$26.6 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$11.9 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.4 Million0.0% of portfolio
-
State Street Corp Boston, MA3.2MShares$11 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $465M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...